Skip to main content
Menu
Home
Show child links of Home
Home
In this section
About Us
Accessibility
Blog
Meet the Team
Contact Us
Privacy and Cookies
Sitemap
Healthcare Professionals
Show child links of Healthcare Professionals
Healthcare Professionals
In this section
Overview of PNH
Who Should Be Tested?
The National PNH Service
Referral Information
Annual Report
Eculizumab Administration Guidelines
Ravulizumab Administration Guidelines
Pegcetacoplan Administration Guidelines
Iptacopan Administration Guidelines
Indications for Treatment with Eculizumab, Ravulizumab and Pegcetacoplan
Meningococcal Infection and Complement Inhibitors
Patient Information
Show child links of Patient Information
Patient Information
In this section
What is PNH?
Diagnosis
Complement Inhibition
Living with PNH
Attending Appointments via Video
Clinical Trials for PNH
Supportive Treatments
Resources
Show child links of Resources
Resources
In this section
PNH Registry
PNH Resources
Outreach Clinics
Charities
Patient Groups
HMDS
Covid-19 & Vaccinations Guidance
Sitemap
Referral Information
Tel: 0113 206 8625
Tel: 020 3299 1039
Home
Patient Information
Patient Information
What is PNH?
What causes PNH?
Signs and Symptoms
Frequently Asked Questions
What to Expect
Additional Tests
Pregnancy and Contraception
Diagnosis
Living with PNH
PNH Patient Perspectives
Travelling and Insurance
Supportive Treatments
Ravulizumab Treatment
Eculizumab Treatment
Pegcetacoplan Treatment
Patient Groups
Attending Appointments via Video
Clinical Trials for PNH
Complement Inhibition
Patient Information
